Eagle Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-473,672
Closed -$48.7M 570
2023
Q2
$48.7M Buy
+473,672
New +$50M 0.27% 125
2023
Q1
Sell
-823,124
Closed -$93.4M 586
2022
Q4
$93.4M Sell
823,124
-99,882
-11% -$8.3M 0.57% 59
2022
Q3
$57.1M Sell
923,006
-408,831
-31% -$28.6M 0.37% 97
2022
Q2
$106M Buy
1,331,837
+19,643
+1% +$1.86M 0.67% 40
2022
Q1
$138M Sell
1,312,194
-109,121
-8% -$10.6M 0.71% 38
2021
Q4
$154M Sell
1,421,315
-95,381
-6% -$10.4M 0.67% 43
2021
Q3
$166M Sell
1,516,696
-325,987
-18% -$33.8M 0.75% 24
2021
Q2
$173M Sell
1,842,683
-584,637
-24% -$53.8M 0.74% 24
2021
Q1
$220M Buy
2,427,320
+187,241
+8% +$15.8M 0.97% 8
2020
Q4
$169M Sell
2,240,079
-686,792
-23% -$51M 0.95% 11
2020
Q3
$229M Buy
2,926,871
+752,602
+35% +$51.8M 1.18% 2
2020
Q2
$120M Buy
2,174,269
+303,708
+16% +$13M 0.68% 31
2020
Q1
$55.4M Sell
1,870,561
-16,755
-0.9% -$567K 0.34% 109
2019
Q4
$68.3M Sell
1,887,316
-617,886
-25% -$18.9M 0.33% 115
2019
Q3
$68.2M Sell
2,505,202
-186,898
-7% -$4.83M 0.35% 106
2019
Q2
$64.8M Sell
2,692,100
-5,377
-0.2% -$136K 0.33% 117
2019
Q1
$71.3M Sell
2,697,477
-7,439
-0.3% -$176K 0.38% 103
2018
Q4
$52.9M Sell
2,704,916
-64,525
-2% -$1.26M 0.33% 119
2018
Q3
$54.2M Buy
2,769,441
+366,348
+15% +$6.97M 0.26% 160
2018
Q2
$39.8M Buy
+2,403,093
New +$36.6M 0.21% 175
2016
Q4
Sell
-1,463,170
Closed -$26.5M 680
2016
Q3
$26.5M Buy
+1,463,170
New +$28.6M 0.18% 172

Other funds holding HZNP